Cargando…

Follistatin-like protein 1 sustains colon cancer cell growth and survival

Follistatin-like protein 1 (FSTL1) is a secreted glycoprotein, which controls several physiological and pathological events. FSTL1 expression is deregulated in many tumors, but its contribution to colon carcinogenesis is not fully understood. Here, we investigated the expression and functional role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bevivino, Gerolamo, Sedda, Silvia, Franzè, Eleonora, Stolfi, Carmine, Di Grazia, Antonio, Dinallo, Vincenzo, Caprioli, Flavio, Facciotti, Federica, Colantoni, Alfredo, Ortenzi, Angela, Rossi, Piero, Monteleone, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101290/ https://www.ncbi.nlm.nih.gov/pubmed/30131854 http://dx.doi.org/10.18632/oncotarget.25811

Ejemplares similares

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue
por: Franzè, Eleonora, et al.
Publicado: (2017)

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death
por: De Simone, Veronica, et al.
Publicado: (2017)

Progranulin sustains STAT3 hyper‐activation and oncogenic function in colorectal cancer cells
por: Laudisi, Federica, et al.
Publicado: (2019)

Reciprocal Regulation Between Smad7 and Sirt1 in the Gut
por: Sedda, Silvia, et al.
Publicado: (2018)

Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis
por: De Simone, Veronica, et al.
Publicado: (2015)

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals
por: Marafini, Irene, et al.
Publicado: (2019)

Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease
por: Di Grazia, Antonio, et al.
Publicado: (2022)

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
por: Di Grazia, Antonio, et al.
Publicado: (2020)

Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis
por: Di Giovangiulio, Martina, et al.
Publicado: (2019)

Lesional Accumulation of CD163-Expressing Cells in the Gut of Patients with Inflammatory Bowel Disease
por: Franzè, Eleonora, et al.
Publicado: (2013)

The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis
por: Di Grazia, Antonio, et al.
Publicado: (2020)

The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation
por: Laudisi, Federica, et al.
Publicado: (2018)

mTOR sustains inflammatory response in celiac disease
por: Sedda, S., et al.
Publicado: (2020)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
por: Stolfi, Carmine, et al.
Publicado: (2011)

A functional role for Smad7 in sustaining colon cancer cell growth and survival
por: Stolfi, C, et al.
Publicado: (2014)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells
por: Maresca, Claudia, et al.
Publicado: (2022)

The Dual Role of Inflammation in Colon Carcinogenesis
por: Monteleone, Giovanni, et al.
Publicado: (2012)

Impact of Food Additives on Gut Homeostasis
por: Laudisi, Federica, et al.
Publicado: (2019)

Smad7 as a positive regulator of intestinal inflammatory diseases
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

Macrophages produce and functionally respond to interleukin-34 in colon cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Defective Expression of Scavenger Receptors in Celiac Disease Mucosa
por: Cupi, Maria Laura, et al.
Publicado: (2014)

Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
por: Troncone, Edoardo, et al.
Publicado: (2021)

Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
por: Monteleone, Giovanni, et al.
Publicado: (2022)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
por: Stolfi, Carmine, et al.
Publicado: (2022)

Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier
por: Stolfi, Carmine, et al.
Publicado: (2023)

Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease
por: Monteleone, Giovanni, et al.
Publicado: (2020)

Short-term Oral Antibiotics Treatment Promotes Inflammatory Activation of Colonic Invariant Natural Killer T and Conventional CD4(+) T Cells
por: Burrello, Claudia, et al.
Publicado: (2018)

Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model
por: Dinallo, Vincenzo, et al.
Publicado: (2019)

Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
por: Salvatori, Silvia, et al.
Publicado: (2023)

Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
por: Stolfi, Carmine, et al.
Publicado: (2012)

Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2012)

Association Between Celiac Disease and Cancer
por: Marafini, Irene, et al.
Publicado: (2020)

The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation
por: Amoroso, Chiara, et al.
Publicado: (2020)

Anthelmintic Drugs as Emerging Immune Modulators in Cancer
por: Stolfi, Carmine, et al.
Publicado: (2023)

Interleukin-34 Enhances the Tumor Promoting Function of Colorectal Cancer-Associated Fibroblasts
por: Franzè, Eleonora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_irbaih6e5jumdv4t5tnekr9tnb